JP2023507610A5 - - Google Patents

Info

Publication number
JP2023507610A5
JP2023507610A5 JP2022537672A JP2022537672A JP2023507610A5 JP 2023507610 A5 JP2023507610 A5 JP 2023507610A5 JP 2022537672 A JP2022537672 A JP 2022537672A JP 2022537672 A JP2022537672 A JP 2022537672A JP 2023507610 A5 JP2023507610 A5 JP 2023507610A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
phenyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022537672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507610A (ja
JP7801223B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/065238 external-priority patent/WO2021126923A1/en
Publication of JP2023507610A publication Critical patent/JP2023507610A/ja
Publication of JP2023507610A5 publication Critical patent/JP2023507610A5/ja
Priority to JP2026000422A priority Critical patent/JP2026053706A/ja
Application granted granted Critical
Publication of JP7801223B2 publication Critical patent/JP7801223B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022537672A 2019-12-19 2020-12-16 Cd206モジュレーター、その使用、および調製方法 Active JP7801223B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000422A JP2026053706A (ja) 2019-12-19 2026-01-05 Cd206モジュレーター、その使用、および調製方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962950488P 2019-12-19 2019-12-19
US62/950,488 2019-12-19
PCT/US2020/065238 WO2021126923A1 (en) 2019-12-19 2020-12-16 Cd206 modulators their use and methods for preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000422A Division JP2026053706A (ja) 2019-12-19 2026-01-05 Cd206モジュレーター、その使用、および調製方法

Publications (3)

Publication Number Publication Date
JP2023507610A JP2023507610A (ja) 2023-02-24
JP2023507610A5 true JP2023507610A5 (https=) 2023-12-06
JP7801223B2 JP7801223B2 (ja) 2026-01-16

Family

ID=74184891

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022537672A Active JP7801223B2 (ja) 2019-12-19 2020-12-16 Cd206モジュレーター、その使用、および調製方法
JP2026000422A Pending JP2026053706A (ja) 2019-12-19 2026-01-05 Cd206モジュレーター、その使用、および調製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026000422A Pending JP2026053706A (ja) 2019-12-19 2026-01-05 Cd206モジュレーター、その使用、および調製方法

Country Status (7)

Country Link
US (1) US20230056497A1 (https=)
EP (1) EP4077297A1 (https=)
JP (2) JP7801223B2 (https=)
CN (1) CN115768757B (https=)
AU (1) AU2020404978A1 (https=)
CA (1) CA3165339A1 (https=)
WO (1) WO2021126923A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210151945A (ko) 2019-04-12 2021-12-14 립타이드 바이오사이언스, 인코포레이티드 대식세포 활성을 조정하기 위한 방법
WO2023192935A1 (en) * 2022-03-30 2023-10-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the treatment for inflammation and fibrosis in retinal neovascular diseases
WO2025247783A1 (en) 2024-05-29 2025-12-04 Syngenta Crop Protection Ag Pesticidally active dihydro-benzoxazinone compounds
WO2025248032A1 (en) 2024-05-31 2025-12-04 Syngenta Crop Protection Ag Pesticidally active indazole compounds
WO2025257072A1 (en) 2024-06-14 2025-12-18 Syngenta Crop Protection Ag Pesticidally active 2-oxobenzimidazole compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US20050009876A1 (en) 2000-07-31 2005-01-13 Bhagwat Shripad S. Indazole compounds, compositions thereof and methods of treatment therewith
DE10207843A1 (de) 2002-02-15 2003-09-04 Schering Ag Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
US20090209577A1 (en) 2004-08-18 2009-08-20 Pfizer Inc. Novel Triazolopyridine Compounds
BRPI0514391A (pt) * 2004-08-18 2008-06-10 Pharmacia & Upjohn Co Llc compostos de triazolopiridina para o tratamento de inflamação
ZA200704889B (en) 2004-11-23 2008-09-25 Celgene Corp JNK inhibitors for treatment of CNS injury
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
ES2642586T3 (es) * 2009-07-27 2017-11-16 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de canales iónicos
EP2742046A1 (en) 2011-08-12 2014-06-18 F.Hoffmann-La Roche Ag PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
EP2818471A1 (en) * 2013-06-27 2014-12-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5
US10016480B2 (en) 2014-10-14 2018-07-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Peptide-based methods for treating pancreatic cancer
WO2016089977A1 (en) 2014-12-03 2016-06-09 Celgene Corporation Substituted indazole compounds, compositions thereof, and methods of treatment therewith
US10730842B2 (en) * 2015-09-03 2020-08-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Small molecule inhibitors of DYRK1A and uses thereof
US20220340983A1 (en) * 2019-09-13 2022-10-27 Massachustts Institute Of Technology Systems and assays for identifying pu.1 inhibitors

Similar Documents

Publication Publication Date Title
JP2023507610A5 (https=)
JP2023515479A5 (https=)
JP6500037B2 (ja) 二環式ピラゾロン化合物および使用方法
JP2020007311A5 (https=)
FI3853234T3 (fi) Fuusioituja trisyklisiä rengasjohdannaisia SRC-homologia-2-fosfataasin estäjinä
AR053011A1 (es) Compuestos de heteroarilo como inhibidores del receptor p2y1, composiciones farmaceuticas que los contienen y su uso en la manufactura de un medicamento para el tratamiento de un trastorno tromboembolico
US20090192127A1 (en) Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
ES2576497T3 (es) Compuesto de piperidina novedoso o sal del mismo
JP2017533266A5 (https=)
DE60320012D1 (de) Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen
ES2895626T3 (es) Derivados de imidazol condensados como inhibidores de TGF-beta
JP2011529474A (ja) cdk阻害剤および抗悪性腫瘍剤を含む治療用組合せ
RU2016137263A (ru) Соединение триазина и его применение в медицинских целях
RU2013145310A (ru) Диспиропирролидиновые производные
RU2005140570A (ru) Фармацевтическая композиция, содержащая ингибитор гистондеацетилазы
JP2014517017A5 (ja) 化合物、その医薬組成物、及び癌治療用の阻害薬としてのその使用
JP2011500685A5 (https=)
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
RU2005127873A (ru) Производные пиразола
RU2008112691A (ru) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
JP2019507114A5 (https=)
KR102940213B1 (ko) Nadph 산화효소 저해제로서의 신규한 화합물
CO5640124A2 (es) Combinacion de un antagonista de mglur2 y un inhibidor de ache para el tratamiento de trastornos neurologicos agudos y/o cronicos
RU2011134283A (ru) Имидазотиазольные производные, имеющие пролиновую циклическую структуру
RU2009114731A (ru) Производное пиразолопиримидина